MRNA earnings call for the period ending September 30, 2019.
News & Analysis: Moderna INC
There's plenty of untapped potential left in genomics, but there are quite a few other omics investors need to know about heading into 2020.
Unfilled promises by biotechs can lead to broken hearts for investors.
The company's long R&D Day presentation gave investors reasons for optimism.
Investors better get ready for a busy week ahead.
MRNA earnings call for the period ending June 30, 2019.
The post-IPO blues hit pretty hard last month.
MRNA earnings call for the period ending March 31, 2019.
Find out how shares of these biopharmaceutical companies outperformed for some lucky investors with great timing.
The biggest-ever biotech IPO heralds enormous promise for a new class of medicines.